Sickle Cell Gene Therapy NHS Offer
This is a Vertex news story, published by BBC, that relates primarily to Casgevy news.
Vertex news
For more Vertex news, you can click here:
more Vertex newsCasgevy news
For more Casgevy news, you can click here:
more Casgevy newsdisease research news
For more disease research news, you can click here:
more disease research newsBBC news
For more news from BBC, you can click here:
more news from BBCAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
sickle cell gene therapy. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest sickle cell disorder news, sickle cells news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
sickle cell diseaseBBC
•Health
Health
NHS to offer 'groundbreaking' sickle cell gene therapy

74% Informative
About 50 people a year with the inherited blood disorder are likely to receive it, experts say.
The one -off treatment Casgevy , also known as Exa-cel, "holds a very real prospect of a cure" A confidential agreement has been made with manufacturer Vertex on how much the NHS will pay.
It is already being given to patients in other countries such as France , Germany and Italy . Wales is also expected to provide it in the next few months ..
VR Score
68
Informative language
62
Neutral language
62
Article tone
informal
Language
English
Language complexity
46
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
2
Source diversity
1
Affiliate links
no affiliate links